Table 2.
Univariate analysis of prognostic factors in mantle cell lymphoma
| Treatment | % 4-Year PFS | Pa | % 4-Year OS | Pa |
| Type | <0.01 | 0.64 | ||
| Intensive (n = 69) | 65 | 84 | ||
| Conventional (n = 19) | 26 | 84 | ||
| MIPI | 0.83 | 0.13 | ||
| Low (n = 44) | 62 | 83 | ||
| Intermediate (n = 24) | 51 | 94 | ||
| High (n = 13) | 48 | 69 | ||
| sMIPI | 0.86 | 0.92 | ||
| Low (n = 42) | 63 | 82 | ||
| Intermediate (n = 28) | 54 | 92 | ||
| High (n = 11) | 43 | 75 | ||
| MIPI-Ki-67 | 0.87 | 0.13 | ||
| Low (n = 14) | 58 | 100 | ||
| Intermediate (n = 42) | 60 | 89 | ||
| High (n = 22) | 46 | 80 |
a
Log-rank test.
PFS, progression-free survival; OS, overall survival; MIPI, mantle cell international prognostic index; sMIPI, simplified MIPI.